Announcements Trials
Browse Landscape

Phase

Phase 2 60Phase 3 21Phase 1 17Phase 1/2 16Phase 2/3 4Phase 4 2Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 13Breast Neoplasms 9Rectal Neoplasms 3Neoplasm Metastasis 2Colonic Neoplasms 2Upper Gastrointestinal Tumours 1TTP 1Stomach Neoplasms 1Recurrence 1Patient Acceptance of Health Care 1Pancreatic Cancer Non-resectable 1Locally Advanced Colorectal Cancer 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1HER-2 Positive Gastric Cancer 1Frailty 1

Interventions

Zoledronic Acid 5Bevacizumab 3exemestane 2Therapeutics 2Standard of Care 2Pamidronate 2Oxaliplatin 2Misoprostol 2Magnetic Resonance Spectroscopy 2Letrozole 2Ibandronic Acid 2Fulvestrant 2Fluorouracil 2Cetuximab 2Capecitabine 2vandetanib 1palbociclib 1liposomal doxorubicin 1huaier 1eribulin 1enzalutamide 1darolutamide 1cabozantinib 1aldesleukin 1abemaciclib 1Vindesine 1Trastuzumab 1Sugars 1Stents 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neoplasm Metastasis × Capecitabine × Clear all
NCT06090994 2025-05-07

Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy

Fudan University

Phase 4 Recruiting
756 enrolled
Gastrointestinal

Neoplasm Metastasis, Recurrence, Colorectal Neoplasms

NCT02248571 2017-11-13

IMPROVE

iOMEDICO AG

Phase 4 Completed
85 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡